+ データを開く
データを開く
- 基本情報
基本情報
| 登録情報 | データベース: PDB / ID: 6g0r | ||||||
|---|---|---|---|---|---|---|---|
| タイトル | Crystal Structure of the first bromodomain of human BRD4 in complex with an acetylated POLR2A peptide (K775ac/K778ac) | ||||||
|  要素 | 
 | ||||||
|  キーワード | TRANSCRIPTION / Bromodomain / complex | ||||||
| 機能・相同性 |  機能・相同性情報 microfibril binding / Abortive elongation of HIV-1 transcript in the absence of Tat / FGFR2 alternative splicing / MicroRNA (miRNA) biogenesis / Viral Messenger RNA Synthesis / Signaling by FGFR2 IIIa TM / RNA Pol II CTD phosphorylation and interaction with CE during HIV infection / RNA Pol II CTD phosphorylation and interaction with CE / HIV Transcription Initiation / RNA Polymerase II HIV Promoter Escape ...microfibril binding / Abortive elongation of HIV-1 transcript in the absence of Tat / FGFR2 alternative splicing / MicroRNA (miRNA) biogenesis / Viral Messenger RNA Synthesis / Signaling by FGFR2 IIIa TM / RNA Pol II CTD phosphorylation and interaction with CE during HIV infection / RNA Pol II CTD phosphorylation and interaction with CE / HIV Transcription Initiation / RNA Polymerase II HIV Promoter Escape / Transcription of the HIV genome / RNA Polymerase II Promoter Escape / RNA Polymerase II Transcription Pre-Initiation And Promoter Opening / RNA Polymerase II Transcription Initiation / RNA Polymerase II Transcription Initiation And Promoter Clearance / Formation of the Early Elongation Complex / Formation of the HIV-1 Early Elongation Complex / mRNA Capping / mRNA Splicing - Minor Pathway / PIWI-interacting RNA (piRNA) biogenesis / RNA polymerase II C-terminal domain binding / P-TEFb complex binding / Processing of Capped Intron-Containing Pre-mRNA / negative regulation of DNA damage checkpoint / Pausing and recovery of Tat-mediated HIV elongation / Tat-mediated HIV elongation arrest and recovery / histone H4 reader activity / RNA polymerase II transcribes snRNA genes / HIV elongation arrest and recovery / Pausing and recovery of HIV elongation / host-mediated suppression of viral transcription / positive regulation of G2/M transition of mitotic cell cycle / Tat-mediated elongation of the HIV-1 transcript / positive regulation of T-helper 17 cell lineage commitment / Formation of HIV-1 elongation complex containing HIV-1 Tat / Formation of HIV elongation complex in the absence of HIV Tat / RNA polymerase II, core complex / RNA Polymerase II Transcription Elongation / Formation of RNA Pol II elongation complex  / :  / RNA Polymerase II Pre-transcription Events / RNA polymerase II CTD heptapeptide repeat kinase activity / mRNA Splicing - Major Pathway / Inhibition of DNA recombination at telomere / positive regulation of RNA splicing / condensed nuclear chromosome / transcription coregulator activity / TP53 Regulates Transcription of DNA Repair Genes / promoter-specific chromatin binding / positive regulation of transcription elongation by RNA polymerase II / Transcriptional regulation by small RNAs / DNA-templated transcription termination / Transcription-Coupled Nucleotide Excision Repair (TC-NER) / Formation of TC-NER Pre-Incision Complex / kinase binding / Activation of anterior HOX genes in hindbrain development during early embryogenesis / DNA-directed RNA polymerase / Dual incision in TC-NER / Gap-filling DNA repair synthesis and ligation in TC-NER / p53 binding / DNA-directed RNA polymerase activity / chromosome / regulation of inflammatory response / 加水分解酵素; エステル加水分解酵素; 5'-リン酸モノエステル産生エキソリボヌクレアーゼ / histone binding / Estrogen-dependent gene expression / Potential therapeutics for SARS / transcription by RNA polymerase II / transcription coactivator activity / hydrolase activity / positive regulation of canonical NF-kappaB signal transduction / transcription cis-regulatory region binding / chromatin remodeling / RNA-directed RNA polymerase / RNA-directed RNA polymerase activity / protein serine/threonine kinase activity / ubiquitin protein ligase binding / DNA damage response / chromatin binding / regulation of DNA-templated transcription / regulation of transcription by RNA polymerase II / chromatin / positive regulation of DNA-templated transcription / enzyme binding / magnesium ion binding / positive regulation of transcription by RNA polymerase II / mitochondrion / DNA binding / RNA binding / zinc ion binding / nucleoplasm / nucleus 類似検索 - 分子機能 | ||||||
| 生物種 |  Homo sapiens (ヒト) | ||||||
| 手法 |  X線回折 /  シンクロトロン /  分子置換 / 解像度: 1.25 Å | ||||||
|  データ登録者 | Filippakopoulos, P. / Picaud, S. / Pike, A.C.W. / von Delft, F. / Arrowsmith, C.H. / Edwards, A.M. / Bountra, C. | ||||||
| 資金援助 |  英国, 1件 
 | ||||||
|  引用 |  ジャーナル: Mol Cell / 年: 2019 タイトル: Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. 著者: Jean-Philippe Lambert / Sarah Picaud / Takao Fujisawa / Huayun Hou / Pavel Savitsky / Liis Uusküla-Reimand / Gagan D Gupta / Hala Abdouni / Zhen-Yuan Lin / Monika Tucholska / James D R ...著者: Jean-Philippe Lambert / Sarah Picaud / Takao Fujisawa / Huayun Hou / Pavel Savitsky / Liis Uusküla-Reimand / Gagan D Gupta / Hala Abdouni / Zhen-Yuan Lin / Monika Tucholska / James D R Knight / Beatriz Gonzalez-Badillo / Nicole St-Denis / Joseph A Newman / Manuel Stucki / Laurence Pelletier / Nuno Bandeira / Michael D Wilson / Panagis Filippakopoulos / Anne-Claude Gingras /          要旨: Targeting bromodomains (BRDs) of the bromo-and-extra-terminal (BET) family offers opportunities for therapeutic intervention in cancer and other diseases. Here, we profile the interactomes of BRD2, ...Targeting bromodomains (BRDs) of the bromo-and-extra-terminal (BET) family offers opportunities for therapeutic intervention in cancer and other diseases. Here, we profile the interactomes of BRD2, BRD3, BRD4, and BRDT following treatment with the pan-BET BRD inhibitor JQ1, revealing broad rewiring of the interaction landscape, with three distinct classes of behavior for the 603 unique interactors identified. A group of proteins associate in a JQ1-sensitive manner with BET BRDs through canonical and new binding modes, while two classes of extra-terminal (ET)-domain binding motifs mediate acetylation-independent interactions. Last, we identify an unexpected increase in several interactions following JQ1 treatment that define negative functions for BRD3 in the regulation of rRNA synthesis and potentially RNAPII-dependent gene expression that result in decreased cell proliferation. Together, our data highlight the contributions of BET protein modules to their interactomes allowing for a better understanding of pharmacological rewiring in response to JQ1. | ||||||
| 履歴 | 
 | 
- 構造の表示
構造の表示
| 構造ビューア | 分子:  Molmil  Jmol/JSmol | 
|---|
- ダウンロードとリンク
ダウンロードとリンク
- ダウンロード
ダウンロード
| PDBx/mmCIF形式 |  6g0r.cif.gz | 77.8 KB | 表示 |  PDBx/mmCIF形式 | 
|---|---|---|---|---|
| PDB形式 |  pdb6g0r.ent.gz | 56 KB | 表示 |  PDB形式 | 
| PDBx/mmJSON形式 |  6g0r.json.gz | ツリー表示 |  PDBx/mmJSON形式 | |
| その他 |  その他のダウンロード | 
-検証レポート
| 文書・要旨 |  6g0r_validation.pdf.gz | 437.1 KB | 表示 |  wwPDB検証レポート | 
|---|---|---|---|---|
| 文書・詳細版 |  6g0r_full_validation.pdf.gz | 437.1 KB | 表示 | |
| XML形式データ |  6g0r_validation.xml.gz | 8.9 KB | 表示 | |
| CIF形式データ |  6g0r_validation.cif.gz | 12.2 KB | 表示 | |
| アーカイブディレクトリ |  https://data.pdbj.org/pub/pdb/validation_reports/g0/6g0r  ftp://data.pdbj.org/pub/pdb/validation_reports/g0/6g0r | HTTPS FTP | 
-関連構造データ
| 関連構造データ |  5nncC  5nndC  5nneC  5nnfC  5nngC  6g0oC  6g0pC  6g0qC  6g0sC  2grcS  2oo1S  2ossS  2ouoS  3d7cS  3daiS  3dwyS S: 精密化の開始モデル C: 同じ文献を引用 ( | 
|---|---|
| 類似構造データ | 
- リンク
リンク
- 集合体
集合体
| 登録構造単位 |  
 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 
 | ||||||||
| 単位格子 | 
 | 
- 要素
要素
| #1: タンパク質 | 分子量: 15099.380 Da / 分子数: 1 / 由来タイプ: 組換発現 / 由来: (組換発現)   Homo sapiens (ヒト) / 遺伝子: BRD4, HUNK1 / プラスミド: pNIC28-Bsa4 / 発現宿主:   Escherichia coli BL21(DE3) (大腸菌) / Variant (発現宿主): R3 / 参照: UniProt: O60885 | 
|---|---|
| #2: タンパク質・ペプチド | 分子量: 1221.362 Da / 分子数: 1 / 由来タイプ: 合成 詳細: POLR2A peptide acetylated at K775 and K778 C-terminal TYR added for UV detection 由来: (合成)  Homo sapiens (ヒト) 参照: UniProt: P24928, DNA-directed RNA polymerase, RNA-directed RNA polymerase | 
| #3: 化合物 | ChemComp-EDO / | 
| #4: 水 | ChemComp-HOH / | 
| Has protein modification | Y | 
-実験情報
-実験
| 実験 | 手法:  X線回折 / 使用した結晶の数: 1 | 
|---|
- 試料調製
試料調製
| 結晶 | マシュー密度: 2.08 Å3/Da / 溶媒含有率: 40.81 % | 
|---|---|
| 結晶化 | 温度: 277 K / 手法: 蒸気拡散法, シッティングドロップ法 / pH: 7 詳細: 20.0 % PEG 6K 10.0 % EtGly 0.1 M HEPES pH 7.0 0.1 M MgCl2 | 
-データ収集
| 回折 | 平均測定温度: 100 K | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 放射光源 | 由来:  シンクロトロン / サイト:  Diamond  / ビームライン: I24 / 波長: 0.9686 Å | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 検出器 | タイプ: DECTRIS PILATUS 6M-F / 検出器: PIXEL / 日付: 2016年5月14日 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 放射波長 | 波長: 0.9686 Å / 相対比: 1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 反射 | 解像度: 1.25→58.52 Å / Num. obs: 37495 / % possible obs: 99.9 % / 冗長度: 5.1 % / Rmerge(I) obs: 0.142 / Rpim(I) all: 0.068 / Rrim(I) all: 0.158 / Rsym value: 0.142 / Net I/av σ(I): 1.8 / Net I/σ(I): 7.3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 反射 シェル | Diffraction-ID: 1 
 | 
-位相決定
| 位相決定 | 手法:  分子置換 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Phasing MR | Model details: Phaser MODE: MR_AUTO 
 | 
- 解析
解析
| ソフトウェア | 
 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 精密化 | 構造決定の手法:  分子置換 開始モデル: Ensemble of 2OSS, 2OUO, 2GRC, 2OO1, 3DAI, 3D7C, 3DWY 解像度: 1.25→39.07 Å / Cor.coef. Fo:Fc: 0.972 / Cor.coef. Fo:Fc free: 0.971 / SU B: 1.353 / SU ML: 0.027 / SU R Cruickshank DPI: 0.0436 / 交差検証法: THROUGHOUT / σ(F): 0 / ESU R: 0.044 / ESU R Free: 0.042 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS U VALUES : REFINED INDIVIDUALLY 
 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 溶媒の処理 | イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.2 Å | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 原子変位パラメータ | Biso  max: 57.34 Å2 / Biso  mean: 16.758 Å2 / Biso  min: 7.05 Å2 
 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化ステップ | サイクル: final / 解像度: 1.25→39.07 Å 
 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 拘束条件 | 
 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS精密化 シェル | 解像度: 1.25→1.282 Å / Rfactor Rfree error: 0  / Total num. of bins used: 20 
 | 
 ムービー
ムービー コントローラー
コントローラー






















 PDBj
PDBj

















